Network origin in Jerome Dauvergne first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Public Company | Biotechnology | 6 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Jerome Dauvergne via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| ONCOMED PHARMACEUTICALS INC | Pharmaceuticals: Major | Director/Board Member Director/Board Member General Counsel | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Director of Finance/CFO Corporate Officer/Principal | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal | |
| Suffolk University | College/University | Undergraduate Degree | |
Delphi Ventures, Inc.
 Delphi Ventures, Inc. Investment ManagersFinance Delphi Ventures Inc (Delphi Ventures) is a venture capital firm founded in 1988 by James Bochnowski. The firm is headquartered in San Mateo, California. | Investment Managers | Private Equity Investor | |
Antipodean Pharmaceuticals, Inc.
 Antipodean Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Antipodean Pharmaceuticals, Inc. manufactures pharmaceutical products and provides pre clinical services. Its product MitoQ, which blocks mitochondrial oxidative damage and prevents cell death. The company was founded in 2002 and is headquartered in Menlo Park, CA. | Pharmaceuticals: Major | Director/Board Member | |
Ilypsa, Inc.
 Ilypsa, Inc. BiotechnologyHealth Technology Ilypsa, Inc. operates a biopharmaceutical firm. It develops renal care pharmaceutical products. The company was founded on March 6, 2003 and is headquartered in Thousand Oaks, CA. | Biotechnology | Director/Board Member | |
| University of Mumbai | College/University | Graduate Degree | |
| Wake Forest University | College/University | Doctorate Degree | |
| ALEXZA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Genesis Merchant Group Securities LLC
 Genesis Merchant Group Securities LLC Investment Banks/BrokersFinance Part of JWGenesis Financial, Inc., Genesis Merchant Group Securities LLC provides security brokerage and dealer services. The company is based in Miami, FL. The company was founded by Barry S. Rosenstein. Genesis Merchant Group Securities was acquired by JWGenesis Financial, Inc. on June 12, 1998 for $15.95 million. | Investment Banks/Brokers | Corporate Officer/Principal | |
| University Court | Director/Board Member | ||
Bloomsbury Genetic Therapies Ltd.
 Bloomsbury Genetic Therapies Ltd. BiotechnologyHealth Technology Bloomsbury Genetic Therapies Ltd. is a British biotechnology company that specializes in developing gene therapy technologies for neurological and metabolic diseases. The company is based in Cambridge, UK. Bloomsbury Genetic Therapies was founded in 2021 by Adrien Lemoine, who has been the CEO since 2021. | Biotechnology | Chairman | |
| ALDER BIOPHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Epidarex Capital Partners LLC
 Epidarex Capital Partners LLC Investment ManagersFinance Epidarex Capital Partners LLC (Epidarex Capital) is a venture capital firm founded in 2010 by Kyparissia Sirinakisvin. The firm is headquartered in Bethesda, Maryland. | Investment Managers | Consultant / Advisor | |
Enhanc3D Genomics Ltd.
 Enhanc3D Genomics Ltd. BiotechnologyHealth Technology Enhanc3D Genomics is a private functional genomics company based in Cambridge, UK. Enhanc3D Genomics is developing a technology to unlock the full potential of the three-dimensional organization of the human genome. The British company's focus is on the non-coding regions of the genome, aiming to identify disease-associated genetic interactions and revolutionize target and biomarker discovery. The company's unique approach has the potential to make precision medicine an everyday reality for patients. Enhanc3D Genomics Ltd. was founded by Mikhail Spivakov, Peter Fraser, and Stefan Schönfelder. The CEO is Hazel Jones. | Biotechnology | Chairman | |
BioCaptiva Ltd.
 BioCaptiva Ltd. BiotechnologyHealth Technology BioCaptiva Ltd. is a British medical device company that is developing the BioCaptis, a device that can transform liquid biopsy testing for cancer management. The company is based in Edinburgh, UK. The BioCaptis captures up to 100x more cell-free DNA (cfDNA) than a venous blood draw, yielding high-quality and quantity cfDNA for testing, which addresses the major challenge of liquid biopsy in cancer management. This will potentially allow the testing of a far greater number of cancer types and stages in a much wider range of patients. BioCaptiva was founded in 2021 when it spun out from the University of Edinburgh. The CEO is Jeremy Wheeler. | Biotechnology | Chairman | |
| ECO ANIMAL HEALTH GROUP PLC | Pharmaceuticals: Major | Director/Board Member | |
Newcells Biotech Ltd.
 Newcells Biotech Ltd. BiotechnologyHealth Technology Newcells Biotech Ltd. operates as a biotechnology company which produces induced pluripotent stem cells and reproducible cell and tissues. Its cell products include human neural progenitor and cardiomyocyte. The firm also provides reprogramming and differentiation services and products. The company was founded by Majlinda Lako and Lyle Armstrong in 2014 and is headquartered in Newcastle Upon Tyne, the United Kingdom. | Biotechnology | Director/Board Member | |
| CELLDEX THERAPEUTICS, INC. | Medical/Nursing Services | Chief Executive Officer | |
| BTG | Pharmaceuticals: Major | Chief Executive Officer | |
Caldan Therapeutics Ltd.
 Caldan Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Caldan Therapeutics Ltd. provides novel therapeutics targeting free fatty acid. It focuses on developing drugs in order to deliver anti-diabetic effects in multiple tissues and organs. The company was founded by Graeme Milligan and Trond Ulven and is headquartered in Edinburgh, the United Kingdom. | Miscellaneous Commercial Services | Chairman | |
Phoqus Pharmaceuticals Plc
 Phoqus Pharmaceuticals Plc Pharmaceuticals: MajorHealth Technology Phoqus Pharmaceuticals Plc develops pharmaceutical products. It's product Chronocort that helps to treat the patients with cortisol deficiency such as congenital adrenal hyperplasia and Addison's diseases. The company was founded in 1998 and is located in West Malling, UK. | Pharmaceuticals: Major | Chief Executive Officer | |
| RELYPSA INC | Pharmaceuticals: Major | Director/Board Member | |
Palleon Pharmaceuticals, Inc.
 Palleon Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Palleon Pharmaceuticals, Inc. operates as biotechnology company. The firm discovers and develops immuno-oncology drugs, medicines, and therapies for the treatment of cancer diseases. It specializes in clinical development, and glyco-immune checkpoint inhibitors. The company was founded by Jim Broderick, Carolyn Bertozzi and Paul Crocker in 2015 and is headquartered in Waltham, MA. | Miscellaneous Commercial Services | Director/Board Member | |
Genzyme Therapeutics Ltd.
 Genzyme Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Genzyme Therapeutics Ltd. develops transformative therapies for patients affected by rare and debilitating diseases. Its treatment areas include thyroid cancer, sclerosis, Fabry disease and Pompe. The company was founded on November 5, 2001 and is headquartered in Oxford, the United Kingdom. | Pharmaceuticals: Major | Corporate Officer/Principal | |
European Biopharmaceutical Enterprises
 European Biopharmaceutical Enterprises BiotechnologyHealth Technology European Biopharmaceutical Enterprises develops biological products. The private company is based in Brussels, Belgium. | Biotechnology | Director/Board Member | |
| University of Durham | College/University | Graduate Degree | |
| SWEDISH ORPHAN BIOVITRUM AB | Pharmaceuticals: Major | Public Communications Contact | |
| ATARA BIOTHERAPEUTICS, INC. | Pharmaceuticals: Major | General Counsel | |
Corixa Corp.
 Corixa Corp. BiotechnologyHealth Technology Corixa Corp. operates as a biopharmaceutical company. It develops and manufactures oncology and immunology products. The firm offers vaccines, immunotherapeutic, monoclonal antibody-based therapeutics, adjuvant and antigen delivery systems, toxin-conjugated, and antigen-specific diagnostic products. The company was founded by Steven H. Gillis and Mark McDade in 1994 and is headquartered in Hamilton, MT. | Biotechnology | General Counsel | |
| PDL BIOPHARMA, INC. | Biotechnology | General Counsel | |
| University of Connecticut | College/University | Undergraduate Degree | |
| Redd Pharmaceuticals, Inc. | Chief Executive Officer | ||
| Frank M Armstrong Consulting ltd | President | ||
| THERAVANCE BIOPHARMA, INC. | Pharmaceuticals: Major | Director/Board Member | |
National Venture Capital Association
 National Venture Capital Association Miscellaneous Commercial ServicesCommercial Services National Venture Capital Association provides business association services. It facilitates networking opportunities and provides research data to its members. The company is headquartered in Washington, DC. | Miscellaneous Commercial Services | Director/Board Member | |
| Advanced Centre for Treatment Research & Education in Cancer | College/University | Graduate Degree | |
| Delphi Ventures III LP | Investment Managers | Corporate Officer/Principal | |
| Delphi Management Partners VII LLC | Corporate Officer/Principal | ||
| Delphi Management Partners VIII LLC | Corporate Officer/Principal | ||
| KARYOPHARM THERAPEUTICS INC. | Pharmaceuticals: Major | Director/Board Member |
Statistics
International
| United States | 33 |
| United Kingdom | 14 |
| India | 3 |
| Canada | 2 |
| Belgium | 2 |
Sectoral
| Health Technology | 27 |
| Finance | 8 |
| Consumer Services | 7 |
| Commercial Services | 6 |
| Health Services | 2 |
Operational
| Director/Board Member | 54 |
| Independent Dir/Board Member | 24 |
| Corporate Officer/Principal | 20 |
| Chairman | 17 |
| Chief Executive Officer | 11 |
Most connected contacts
| Insiders | |
|---|---|
| Frank Armstrong | 41 |
| Deepa Pakianathan | 32 |
| Michael Wyzga | 31 |
| Jill Henrich | 7 |
| Wills Hughes-Wilson | 6 |
| Richard Francis | 2 |
- Stock Market
- Insiders
- Jerome Dauvergne
- Company connections
